Eloxx Pharmaceuticals Inc (ELOX)
0.855
0.00 (0.00%)
USD |
OTCM |
May 07, 11:47
Eloxx Pharmaceuticals Total Liabilities (Quarterly): 26.09M for Sept. 30, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
September 30, 2023 | 26.09M |
June 30, 2023 | 24.59M |
March 31, 2023 | 23.49M |
December 31, 2022 | 31.78M |
September 30, 2022 | 31.86M |
June 30, 2022 | 31.13M |
March 31, 2022 | 31.93M |
December 31, 2021 | 22.76M |
September 30, 2021 | 22.38M |
June 30, 2021 | 19.97M |
March 31, 2021 | 17.62M |
December 31, 2020 | 16.25M |
September 30, 2020 | 17.86M |
June 30, 2020 | 19.63M |
March 31, 2020 | 20.78M |
December 31, 2019 | 22.73M |
September 30, 2019 | 22.83M |
June 30, 2019 | 23.82M |
March 31, 2019 | 22.46M |
December 31, 2018 | 7.807M |
September 30, 2018 | 5.079M |
June 30, 2018 | 4.447M |
March 31, 2018 | 5.651M |
September 30, 2017 | 3.276M |
June 30, 2017 | 4.974M |
Date | Value |
---|---|
March 31, 2017 | 3.258M |
December 31, 2016 | 2.964M |
September 30, 2016 | 3.387M |
June 30, 2016 | 4.665M |
March 31, 2016 | 4.918M |
December 31, 2015 | 6.919M |
September 30, 2015 | 6.935M |
June 30, 2015 | 7.323M |
March 31, 2015 | 5.714M |
December 31, 2014 | 6.614M |
September 30, 2014 | 5.707M |
June 30, 2014 | 5.845M |
March 31, 2014 | 1.155M |
December 31, 2013 | 3.381M |
September 30, 2013 | 3.697M |
June 30, 2013 | 3.312M |
March 31, 2013 | 3.580M |
December 31, 2012 | 3.883M |
September 30, 2012 | 3.631M |
June 30, 2012 | 3.502M |
March 31, 2012 | 4.036M |
December 31, 2011 | 4.024M |
September 30, 2011 | 4.339M |
June 30, 2011 | 4.079M |
March 31, 2011 | 4.194M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
16.25M
Minimum
Dec 2020
31.93M
Maximum
Mar 2022
23.75M
Average
22.79M
Median
Total Liabilities (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | 5.72M |
Palatin Technologies Inc | 24.94M |
iBio Inc | 24.82M |
Theriva Biologics Inc | 15.52M |
Oragenics Inc | 1.798M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 6.042M |
Shareholders Equity (Quarterly) | -20.05M |